ATE484523T1 - Igg2 antikörper gegen exkretion sekretion antigenen von leishmania promastigoten oder amastigoten - Google Patents

Igg2 antikörper gegen exkretion sekretion antigenen von leishmania promastigoten oder amastigoten

Info

Publication number
ATE484523T1
ATE484523T1 AT03750846T AT03750846T ATE484523T1 AT E484523 T1 ATE484523 T1 AT E484523T1 AT 03750846 T AT03750846 T AT 03750846T AT 03750846 T AT03750846 T AT 03750846T AT E484523 T1 ATE484523 T1 AT E484523T1
Authority
AT
Austria
Prior art keywords
amastigotes
antibodies against
igg2 antibodies
leishmania
leishmania promastigotes
Prior art date
Application number
AT03750846T
Other languages
English (en)
Inventor
Gerard Papierok
Serge Vicens
Jean-Loup Lemesre
Original Assignee
Bio Veto Tests Bvt Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Veto Tests Bvt Sarl filed Critical Bio Veto Tests Bvt Sarl
Application granted granted Critical
Publication of ATE484523T1 publication Critical patent/ATE484523T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03750846T 2002-07-26 2003-07-25 Igg2 antikörper gegen exkretion sekretion antigenen von leishmania promastigoten oder amastigoten ATE484523T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0209506A FR2842813B1 (fr) 2002-07-26 2002-07-26 ANTICORPS D'ISOTYPES PARTICULIERS ANTI ANTIGENES D'EXCRETION SECRETION DE PROMASTIGOTES OU D'AMASTIGOTES DE Leishmania sp
PCT/FR2003/002358 WO2004011500A2 (fr) 2002-07-26 2003-07-25 Anticorps d'isotypes igg2 anti antigenes d’excretion secretion de promastigotes ou d’amastigotes de leishmania

Publications (1)

Publication Number Publication Date
ATE484523T1 true ATE484523T1 (de) 2010-10-15

Family

ID=30011514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03750846T ATE484523T1 (de) 2002-07-26 2003-07-25 Igg2 antikörper gegen exkretion sekretion antigenen von leishmania promastigoten oder amastigoten

Country Status (8)

Country Link
US (1) US20060140955A1 (de)
EP (1) EP1539821B1 (de)
AT (1) ATE484523T1 (de)
AU (1) AU2003269060A1 (de)
DE (1) DE60334550D1 (de)
ES (1) ES2354213T3 (de)
FR (1) FR2842813B1 (de)
WO (1) WO2004011500A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618680B1 (fr) * 1987-07-31 1990-05-11 Pasteur Institut Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques
FR2829767B1 (fr) * 2001-09-14 2004-02-27 Gerard Papierok Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes

Also Published As

Publication number Publication date
AU2003269060A1 (en) 2004-02-16
DE60334550D1 (de) 2010-11-25
AU2003269060A8 (en) 2004-02-16
WO2004011500A3 (fr) 2004-03-25
FR2842813A1 (fr) 2004-01-30
EP1539821A2 (de) 2005-06-15
EP1539821B1 (de) 2010-10-13
US20060140955A1 (en) 2006-06-29
FR2842813B1 (fr) 2007-06-01
ES2354213T3 (es) 2011-03-11
WO2004011500A2 (fr) 2004-02-05

Similar Documents

Publication Publication Date Title
ATE477273T1 (de) Humanisierte antikoerper gegen gamma-interferon
DE122012000001I1 (de) Humane antikorper gegen CTLA-4 und deren verwendungen.
EP1554311A4 (de) Humanisierte antikörper, die beta amyloid-peptid erkennen
CY2019022I1 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
FR18C1023I2 (fr) Variants d'immunoglobuline et utilisations
ATE423571T1 (de) Verwendung von bispezifischen antikörpern gegen einen aktivierenden rezeptor fcepsilonri und gegen einen inhibierenden rezeptor ox2ra (cd200ra) zur regulierung der immunantworten
EP1636268A4 (de) Humanisierte antikörper, die beta amyloid-peptid erkennen
ATE549033T1 (de) Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper
WO2004001381A3 (en) Novel raag10 cell surface target and a family of antibodies recognizing that target
TR200300478T2 (tr) Hümanize antiLT-ß-R antikorları
IL165193A (en) Humanized immunomodulatory monoclonal antibodies and use thereof for the treatment of neoplastic disease
DK1432735T3 (da) Antagonistiske humane anti-htnfsf13b-antistoffer
IL166632A (en) Antibody that binds an alpha-fetoprotein antigen and fusion protein comprising such
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
ATE366746T1 (de) Gegen das semp1-protein gerichtete antikörper, verfahren zu deren herstellung, und deren anwendungen
EP2260843A3 (de) Alpha-MSH und Derivate zur Induktion von Antigentoleranz
WO2004060295A3 (en) Methods of inducing and maintaining immune tolerance
EP1230932A3 (de) Verwendung von Antikörpern zur Vakzinierung gegen Krebs
EP1530579A4 (de) Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
ATE484523T1 (de) Igg2 antikörper gegen exkretion sekretion antigenen von leishmania promastigoten oder amastigoten
DE59914163D1 (de) Induktion einer Tumorimmunität durch Redirektion von Tumorzellen gegen Antigen-präsentierende Zellen
ATE537759T1 (de) Verbesserte zwinge
UA47374S (uk) 1. підвісок «хрест страждання господа»

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties